money Business News

Novo says Wegovy injection lowers BMI and obesity rates in children in trial

Wegovy is already approved to treat obesity in children ages 12 and older, but there are currently no approved medications for those under 12.

Published by on
Novo says Wegovy injection lowers BMI and obesity rates in children in trial
Source: Business News

Novo says Wegovy injection lowers BMI and obesity rates in children in trial

Wegovy is already approved to treat obesity in children ages 12 and older, but there are currently no approved medications for those under 12.

This story was automatically imported from our syndicated feed coverage. Full updates are being tracked closely as more details emerge from local correspondents and global news wires.

Our editorial team is continuously monitoring this topic to bring you the latest developments. Check back regularly for detailed follow-up articles, background analyses, and video broadcasts from the scene.

Reporting sponsored by News Portal Syndicated Coverage.